Biomedica Italia, has signed a distribution agreement with Accel-Heal Technologies Limited, a UK-based company pioneering innovative wound care technologies, for the distribution of Accel-Heal Solo.
Accel-Heal Solo is a non-invasive electro-stimulation device that provides targeted therapy for hard-to-heal and painful wounds, such as leg ulcers, diabetic foot ulcers, and pressure sores. Electro-stimulation has been shown to accelerate wound healing, reduce pain, and improve patients’ quality of life.
With this agreement, Biomedica Italia confirms its commitment to finding innovative solutions to improve the quality of patient care.

Go to product page click here